Genetically modified pigs to model human diseases

Journal of Applied Genetics

Volumn 55, Issue 1, 2014, Pages 53-64

  Flisikowska, Tatiana ^a   Kind, Alexander ^a   Schnieke, Angelika ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Disease model; Gene targeting; Pig; Swine; TALENs; Transgenic; ZFNs

Indexed keywords

ADENOSINE DEAMINASE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CHEMOKINE RECEPTOR; DOXORUBICIN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; JANUS KINASE 3; LOW DENSITY LIPOPROTEIN RECEPTOR; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRESENILIN 1; PRESENILIN 2; RHODOPSIN; SURVIVAL MOTOR NEURON PROTEIN 1;

ALZHEIMER DISEASE; BLEEDING DISORDER; CARDIOVASCULAR DISEASE; CYSTIC FIBROSIS; DIABETES MELLITUS; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GLUCOSE METABOLISM; HEMOPHILIA A; HUMAN; HUNTINGTON CHOREA; KIDNEY POLYCYSTIC DISEASE; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; RETINITIS PIGMENTOSA; REVIEW; SPINAL MUSCULAR ATROPHY; STARGARDT DISEASE; TRANSGENIC ORGANISM; X LINKED SEVERE COMBINED IMMUNODEFICIENCY; ANIMAL; DISEASE MODEL; GENETICS; SWINE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; HUMANS; SWINE;

EID: 84893618608     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-013-0182-9     Document Type: Review

References (122)

1. Adam M, Bayer C, Henke J, Grosu A, Molls M, Nieder C (2008) Tirapazamine plus cisplatin and irradiation in a mouse model: improved tumor control at the cost of increased toxicity. J Cancer Res Clin Oncol 134: 137-146.
2. Aigner B, Rathkolb B, Herbach N, Hrabé de Angelis M, Wanke R, Wolf E (2008) Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects. Am J Physiol Endocrinol Metab 294: E232-E240.
3. Al-Mashhadi RH, Sørensen CB, Kragh PM, Christoffersen C, Mortensen MB, Tolbod LP et al (2013) Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med 5: 166ra1. doi: 10. 1126/scitranslmed. 3004853.
4. Barrow RT, Lollar P (2006) Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII. J Thromb Haemost 4: 2223-2229.
5. Baxa M, Hruska-Plochan M, Juhas S, Vodicka P, Pavlok A, Juhasova J et al (2013) A transgenic minipig model of Huntington's disease. J Huntingtons Dis 2: 47-68.
6. Bebee TW, Dominguez CE, Chandler DS (2012) Mouse models of SMA: tools for disease characterization and therapeutic development. Hum Genet 131: 1277-1293.
7. Benson S, Wu J, Padmanabhan S, Kurtz TW, Pershadsingh HA (2000) Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone. Am J Hypertens 13: 74-82.
8. Bentzon JF, Falk E (2010) Atherosclerotic lesions in mouse and man: is it the same disease? Curr Opin Lipidol 21: 434-440.
9. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr (1995) Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10: 119-121.
10. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R et al (2003) Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124: 762-777.
11. Bragonzi A (2010) Murine models of acute and chronic lung infection with cystic fibrosis pathogens. Int J Med Microbiol 300: 584-593.
12. Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M et al (2012) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci U S A 109: 17382-17387.
13. Cohn JS, Patterson BW, Uffelman KD, Davignon J, Steiner G (2004) Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J Clin Endocrinol Metab 89: 3949-3955.
14. Cowley BD Jr, Smardo FL Jr, Grantham JJ, Calvet JP (1987) Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sci U S A 84: 8394-8398.
15. Croner RS, Brueckl WM, Reingruber B, Hohenberger W, Guenther K (2005) Age and manifestation related symptoms in familial adenomatous polyposis. BMC Cancer 5: 24.
16. Dekel B, Burakova T, Arditti FD, Reich-Zeliger S, Milstein O, Aviel-Ronen S et al (2003) Human and porcine early kidney precursors as a new source for transplantation. Nat Med 9: 53-60.
17. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M (1999) Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 19: 2981-2992.
18. Edwards AO, Miedziak A, Vrabec T, Verhoeven J, Acott TS, Weleber RG et al (1999) Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14. Am J Ophthalmol 127: 426-435.
19. Fischer A, Cavazzana-Calvo M, De Saint Basile G, DeVillartay JP, Di Santo JP, Hivroz C et al (1997) Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol 15: 93-124.
20. Flisikowska T, Thorey IS, Offner S, Ros F, Lifke V, Zeitler B et al (2011) Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS One 6: e21045. doi: 10. 1371/journal. pone. 0021045.
21. Flisikowska T, Merkl C, Landmann M, Eser S, Rezaei N, Cui X et al (2012) A porcine model of familial adenomatous polyposis. Gastroenterology 143: 1173-1175. e7.
22. Fodde R, Smits R (2001) Disease model: familial adenomatous polyposis. Trends Mol Med 7: 369-373.
23. Frese KK, Tuveson DA (2007) Maximizing mouse cancer models. Nat Rev Cancer 7: 645-658.
24. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
25. Gabow PA (1993) Autosomal dominant polycystic kidney disease. Am J Kidney Dis 22: 511-512.
26. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C et al (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523-527.
27. Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359: 1477-1485.
28. Groenen MA, Archibald AL, Uenishi H, Tuggle CK, Takeuchi Y, Rothschild MF et al (2012) Analyses of pig genomes provide insight into porcine demography and evolution. Nature 491: 393-398.
29. Guilbault C, Saeed Z, Downey GP, Radzioch D (2007) Cystic fibrosis mouse models. Am J Respir Cell Mol Biol 36: 1-7.
30. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE et al (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306: 234-238.
31. Hao YH, Yong HY, Murphy CN, Wax D, Samuel M, Rieke A et al (2006) Production of endothelial nitric oxide synthase (eNOS) over-expressing piglets. Transgenic Res 15: 739-750.
32. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
33. Hasty AH, Shimano H, Osuga J, Namatame I, Takahashi A, Yahagi N et al (2001) Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276: 37402-37408.
34. Hauschild J, Petersen B, Santiago Y, Queisser AL, Carnwath JW, Lucas-Hahn A et al (2011) Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci U S A 108: 12013-12017.
35. He J, Ye J, Li Q, Feng Y, Bai X, Chen X et al (2013) Construction of a transgenic pig model overexpressing polycystic kidney disease 2 (PKD2) gene. Transgenic Res 22: 861-867.
36. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH et al (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7: 469-483.
37. Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
38. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
39. Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH et al (2000) A mouse model for spinal muscular atrophy. Nat Genet 24: 66-70.
40. Humphries MM, Rancourt D, Farrar GJ, Kenna P, Hazel M, Bush RA et al (1997) Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat Genet 15: 216-219.
41. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92: 883-893.
42. Jacobsen JC, Bawden CS, Rudiger SR, McLaughlan CJ, Reid SJ, Waldvogel HJ et al (2010) An ovine transgenic Huntington's disease model. Hum Mol Genet 19: 1873-1882.
43. Jiang C, Ting AT, Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
44. Kashiwakura Y, Mimuro J, Onishi A, Iwamoto M, Madoiwa S, Fuchimoto D et al (2012) Porcine model of hemophilia A. PLoS One 7(11): e49450. doi: 10. 1371/journal. pone. 0049450.
45. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S (1993) Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 18: 467-472.
46. Klymiuk N, Blutke A, Graf A, Krause S, Burkhardt K, Wuensch A et al (2013) Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Hum Mol Genet 22: 4368-4382.
47. Knowles JW, Maeda N (2000) Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 2336-2345.
48. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T et al (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45: 498-506.
49. Kragh PM, Nielsen AL, Li J, Du Y, Lin L, Schmidt M et al (2009) Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw. Transgenic Res 18: 545-558.
50. Lanoix J, D'Agati V, Szabolcs M, Trudel M (1996) Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 13: 1153-1160.
51. Lauer N, Suvorava T, Rüther U, Jacob R, Meyer W, Harrison DG et al (2005) Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase. Cardiovasc Res 65: 254-262.
52. Leblond V, Autran B, Cesbron JY (1997) The SCID mouse mutant: definition and potential use as a model for immune and hematological disorders. Hematol Cell Ther 39: 213-221.
53. Leonard WJ (1996) The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu Rev Med 47: 229-239.
54. Leuchs S, Saalfrank A, Merkl C, Flisikowska T, Edlinger M, Durkovic M et al (2012) Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. PLoS One 7: e43323. doi: 10. 1371/journal. pone. 0043323.
55. Li XJ, Li S (2012) Influence of species differences on the neuropathology of transgenic Huntington's disease animal models. J Genet Genomics 39: 239-245.
56. Li T, Snyder WK, Olsson JE, Dryja TP (1996) Transgenic mice carrying the dominant rhodopsin mutation P347S: evidence for defective vectorial transport of rhodopsin to the outer segments. Proc Natl Acad Sci U S A 93: 14176-14181.
57. Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 96: 6307-6311.
58. Lorson MA, Spate LD, Samuel MS, Murphy CN, Lorson CL, Prather RS et al (2011) Disruption of the Survival Motor Neuron (SMN) gene in pigs using ssDNA. Transgenic Res 20: 1293-1304.
59. Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X et al (1997) Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet 17: 179-181.
60. Lu H, Huang D, Ransohoff RM, Zhou L (2011) Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J 25: 3344-3355.
61. Luo Y, Li J, Liu Y, Lin L, Du Y, Li S et al (2011) High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer. Transgenic Res 20: 975-988.
62. Mannucci PM, Tuddenham EG (2001) The hemophilias-from royal genes to gene therapy. N Engl J Med 344: 1773-1779.
63. Martignoni M, Groothuis GM, de Kanter R (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2: 875-894.
64. Mashimo T, Takizawa A, Voigt B, Yoshimi K, Hiai H, Kuramoto T et al (2010) Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One 5: e8870. doi: 10. 1371/journal. pone. 0008870.
65. Mashimo T, Takizawa A, Kobayashi J, Kunihiro Y, Yoshimi K, Ishida S et al (2012) Generation and characterization of severe combined immunodeficiency rats. Cell Rep 2: 685-694.
66. McCalla-Martin AC, Chen X, Linder KE, Estrada JL, Piedrahita JA (2010) Varying phenotypes in swine versus murine transgenic models constitutively expressing the same human Sonic hedgehog transcriptional activator, K5-HGLI2 Delta N. Transgenic Res 19: 869-887.
67. McCreath KJ, Howcroft J, Campbell KH, Colman A, Schnieke AE, Kind AJ (2000) Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature 405: 1066-1069.
68. Midgley CA, Lane DP (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15: 1179-1189.
69. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ et al (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342.
70. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH et al (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8: 1177-1183.
71. Morrison AE, Ludlam CA, Kessler C (1993) Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 81: 1513-1520.
72. Mousavi SA, Berge KE, Leren TP (2009) The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis. J Intern Med 266: 507-519.
73. Mussolino C, Cathomen T (2013) RNA guides genome engineering. Nat Biotechnol 31: 208-209.
74. Nakamura A, Takeda S (2011) Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications. J Biomed Biotechnol 2011: 184393. doi: 10. 1155/2011/184393.
75. Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF et al (2004) Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept 122: 209-217.
76. Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471.
77. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS et al (2008) Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. J Immunol 181: 5817-5827.
78. Olsson JE, Gordon JW, Pawlyk BS, Roof D, Hayes A, Molday RS et al (1992) Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 9: 815-830.
79. Parekh AK, Barton MB (2010) The challenge of multiple comorbidity for the US health care system. JAMA 303: 1303-1304.
80. Petters RM, Alexander CA, Wells KD, Collins EB, Sommer JR, Blanton MR et al (1997) Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat Biotechnol 15: 965-970.
81. Pignatelli PM, Pound SE, Carothers AD, Macnicol AM, Allan PL, Watson ML et al (1992) Multipoint mapping of adult onset polycystic kidney disease (PKD1) on chromosome 16. J Med Genet 29: 638-641.
82. Plum L, Wunderlich FT, Baudler S, Krone W, Brüning JC (2005) Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives. Physiology (Bethesda) 20: 152-161.
83. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG et al (1999) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
84. Pritchard L, Sloane-Stanley JA, Sharpe JA, Aspinwall R, Lu W, Buckle V et al (2000) A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum Mol Genet 9: 2617-2627.
85. Renner S, Fehlings C, Herbach N, Hofmann A, von Waldthausen DC, Kessler B et al (2010) Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes 59: 1228-1238.
86. Renner S, Römisch-Margl W, Prehn C, Krebs S, Adamski J, Göke B et al (2012) Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced beta-cell mass. Diabetes 61: 2166-2175.
87. Renner S, Braun-Reichhart C, Blutke A, Herbach N, Emrich D, Streckel E et al (2013) Permanent neonatal diabetes in INS(C94Y) transgenic pigs. Diabetes 62(5): 1505-1511.
88. Reznikov LR, Dong Q, Chen JH, Moninger TO, Park JM, Zhang Y et al (2013) CFTR-deficient pigs display peripheral nervous system defects at birth. Proc Natl Acad Sci U S A 110: 3083-3038.
89. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
90. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
91. Rogers CS, Hao Y, Rokhlina T, Samuel M, Stoltz DA, Li Y et al (2008a) Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 118: 1571-1577.
92. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ et al (2008b) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321: 1837-1841.
93. Ross JW, Fernandez de Castro JP, Zhao J, Samuel M, Walters E, Rios C et al (2012) Generation of an inbred miniature pig model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 53: 501-507.
94. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864-870.
95. Schnieke AE, Kind AJ, Ritchie WA, Mycock K, Scott AR, Ritchie M et al (1997) Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278: 2130-2133.
96. Schrank B, Götz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG et al (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A 94: 9920-9925.
97. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507-3512.
98. Sommer JR, Estrada JL, Collins EB, Bedell M, Alexander CA, Yang Z et al (2011) Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. Br J Ophthalmol 95: 1749-1754.
99. Soutar AK (2011) Unexpected roles for PCSK9 in lipid metabolism. Curr Opin Lipidol 22: 192-196.
100. Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44: 8-19.
101. Stoltz DA, Rokhlina T, Ernst SE, Pezzulo AA, Ostedgaard LS, Karp PH et al (2013) Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs. J Clin Invest 123: 2685-2693.
102. Suzuki S, Iwamoto M, Saito Y, Fuchimoto D, Sembon S, Suzuki M et al (2012) Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 10: 753-758.
103. Takakura A, Contrino L, Zhou X, Bonventre JV, Sun Y, Humphreys BD et al (2009) Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet 18: 2523-2531.
104. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M et al (2000) Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 157: 331-339.
105. Tan W, Carlson DF, Lancto CA, Garbe JR, Webster DA, Hackett PB et al (2013) Efficient nonmeiotic allele introgression in livestock using custom endonucleases. Proc Natl Acad Sci U S A 110: 16526-16531.
106. Thomas S, Kotamraju S, Zielonka J, Harder DR, Kalyanaraman B (2007) Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: a bell-shaped signaling response. Free Radic Biol Med 42: 1049-1061.
107. Toschi V (2010) OBI-1, porcine recombinant Factor VIII for the potential treatment of patients with congenital hemophilia A and alloantibodies against human Factor VIII. Curr Opin Mol Ther 12: 617-625.
108. Uchida M, Shimatsu Y, Onoe K, Matsuyama N, Niki R, Ikeda JE et al (2001) Production of transgenic miniature pigs by pronuclear microinjection. Transgenic Res 10: 577-582.
109. Umeyama K, Watanabe M, Saito H, Kurome M, Tohi S, Matsunari H et al (2009) Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs. Transgenic Res 18: 697-706.
110. Vickers P (2009) Severe combined immune deficiency: early hospitalisation and isolation. Wiley-Blackwell, Chichester.
111. Wei J, Ouyang H, Wang Y, Pang D, Cong NX, Wang T et al (2012) Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII. FEBS J 279: 91-99.
112. Whyte JJ, Samuel M, Mahan E, Padilla J, Simmons GH, Arce-Esquivel AA et al (2011) Vascular endothelium-specific overexpression of human catalase in cloned pigs. Transgenic Res 20: 989-1001.
113. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M et al (1996) Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384: 455-458.
114. Yamagata K, Yang Q, Yamamoto K, Iwahashi H, Miyagawa J, Okita K et al (1998) Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes 47: 1231-1235.
115. Yamakawa H, Nagai T, Harasawa R, Yamagami T, Takahashi J, Ishikawa KI et al (1999) Production of transgenic pig carrying MMTV/v-Ha-ras. J Reprod Dev 45: 111-118.
116. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC et al (2008) Towards a transgenic model of Huntington's disease in a non-human primate. Nature 453: 921-924.
117. Yang D, Wang CE, Zhao B, Li W, Ouyang Z, Liu Z et al (2010) Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet 19: 3983-3994.
118. Yang D, Yang H, Li W, Zhao B, Ouyang Z, Liu Z et al (2011) Generation of PPARgamma mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning. Cell Res 21: 979-982.
119. Ye J, He J, Li Q, Feng Y, Bai X, Chen X et al (2013) Generation of c-Myc transgenic pigs for autosomal dominant polycystic kidney disease. Transgenic Res, Mar 30 [Epub ahead of print].
120. Zaidi A, Schmoeckel M, Bhatti F, Waterworth P, Tolan M, Cozzi E et al (1998) Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65: 1584-1590.
121. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.
122. Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90: 905-981.